Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases.

Blanche, F; Cameron, B; Bernard, F X; Maton, L; Manse, B; Ferrero, L; Ratet, N; Lecoq, C; Goniot, A; Bisch, D; Crouzet, J

Blanche, F; Cameron, B; Bernard, F X; Maton, L; Manse, B; Ferrero, L; Ratet, N; Lecoq, C; Goniot, A; Bisch, D; Crouzet, J.

Affiliation

Blanche F; Department of Molecular Microbiology, Rhône-Poulenc Rorer S.A., Vitry-sur-Seine, France. francis.blanche@rp.fr

Antimicrob Agents Chemother ; 40(12): 2714-20, 1996 Dec.

Article in En | MEDLINE | ID: mdl-9124828

Subject(s)

DNA Topoisomerases, Type II/chemistry; DNA, Bacterial/chemistry; Escherichia coli/enzymology; Fluoroquinolones; Staphylococcus aureus/enzymology; Anti-Bacterial Agents/pharmacology; Anti-Infective Agents/pharmacology; DNA Topoisomerase IV; DNA Topoisomerases, Type II/isolation & purification; DNA, Bacterial/isolation & purification; Escherichia coli/genetics; Novobiocin/pharmacology; Ofloxacin/pharmacology; Quinolones/pharmacology; Staphylococcus aureus/genetics; Substrate Specificity; Topoisomerase II Inhibitors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcus aureus / DNA, Bacterial / DNA Topoisomerases, Type II / Fluoroquinolones / Escherichia coli Language: En Journal: Antimicrob Agents Chemother Year: 1996 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google